期刊文献+

新耐药基因HA117多克隆抗体的制备与鉴定 被引量:2

Preparation and identification of polyclonal antibodies of novel multidrug resistance gene HA117
下载PDF
导出
摘要 目的制备HA117多克隆抗体。方法以HA117表达质粒pAdTrack-HA117为模板,PCR扩增HA117基因,扩增产物转入BL21(DE3)感受态细胞,进行HA117蛋白诱导表达,采用SDS-PAGE检测表达产物。纯化HA117蛋白后免疫新西兰大白兔,制备多克隆抗体。通过间接ELISA检测其效价。将转染携带HA117重组腺病毒的HEK293细胞为实验组,未转染的HEK293细胞为对照组,用细胞免疫荧光和Western blot方法检测其过表达的HA117蛋白,验证制备的HA117多克隆抗体的特异性。结果成功获得HA117多克隆抗体,间接ELISA法检测显示抗HA117血清效价为1∶729 000。细胞免疫荧光和Western blot检测示制备的HA117多克隆抗体可以特异性识别HA117抗原蛋白。结论获得了效价和特异性较高的HA117多克隆抗体。 Objective To prepare polyclonal antibodies of a novel multidrug resistance gene,HA117.Methods pAdTrack-HA117 plasmid was used as the template to amplify the total cDNA of HA117 by using PCR.The products of PCR were transferred into BL21(DE3) competent cells to induce the protein expression of HA117 and identified by SDS-PAGE.New Zealand rabbits were immunized with HA117 protein after been purified in order to get the polyclonal antibodies of HA117.Indirect ELISA was used to detect the titer of the polyclonal antibodies of HA117.Adenovirus vector encoding HA117 gene was transducted into HEK293.Immunofluorescence staining and Western blot analysis were used to detect the specificity of polyclonal antibodies.Results Polyclonal antibodies of HA117 were obtained successfully.The anti-HA117 serum titer was 1∶729 000 by indirect ELISA.The polyclone antibody of HA117 identified the HA117 protein in transducted HEK293 specifically by immunofluorescence staining and Western bolt analysis.Conclusion Our prepared polyclonal antibodies of HA117 are of high titer and high specificity.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2011年第11期1128-1131,共4页 Journal of Third Military Medical University
基金 国家自然科学基金面上项目(39970768)~~
关键词 HA117 多克隆抗体 抗体制备 鉴定 HA117 polyclonal antibody preparation identification
  • 相关文献

参考文献20

  • 1Huang M E, Ye Y C, Chen S R, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia [ J ]. Blood, 1988, 72 (2) : 567 - 572.
  • 2Tomiyama N, Matzno S, Kitada C, et al. The possibility of simvastatin as a chemotherapeutic agent for all-trans retinoic acid-resistant promyelocytic leukemia[ J]. Biol Pharm Bull, 2008, 31 (3) : 369 - 374.
  • 3Aribi A, Kantarjian H M, Estey E H, et al. Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia[ J ]. Cancer, 2007, 109 (7) :1355 -1359.
  • 4Warrell R P Jr, Frankel S R, Miller W H Jr, et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin ( all-trans-retinoic acid) [J]. N Engl J Med, 1991, 324(20) : 1385 -1393.
  • 5郑改焕,金先庆,罗庆,郭玉霞,宿玉玺,徐酉华.新基因HA117最佳siRNA的筛选及重组腺病毒构建[J].第三军医大学学报,2009,31(7):641-643. 被引量:3
  • 6Zheng G H, Fu J R, Xu Y H, et al. Screening and cloning of multidrug resistant genes in HL-60/MDR cells [ J ]. Leuk Res, 2009, 33 (8): 1120-1123.
  • 7郑改焕,金先庆,郭玉霞,罗庆,徐酉华.新基因HA117在淋巴瘤细胞中的耐药相关功能研究[J].肿瘤,2009,29(4):315-318. 被引量:7
  • 8车艳,徐酉华,郑改焕,郭玉霞.新基因HA117在儿童急性白血病中的表达及其临床意义[J].四川大学学报(医学版),2009,40(5):873-876. 被引量:4
  • 9Guo Y, Zheng G, Jin X, et al. HA117 gene increased the muhidrug resistance of K562 cells in vitro: an investigation to the function of a novel genc related to drug resistance [ J]. J Exp Clin Cancer Res, 2009, 28: 63.
  • 10Zhao L, Jin X, Xu Y, et al. Functional study of the novel muhidrug resistance gene HA117 and its comparison to multidrug resistance gene 1[J]. JExpClinCancerRes, 2010, 29: 98.

二级参考文献47

共引文献14

同被引文献23

  • 1蔺涛.肿瘤多药耐药的研究进展[J].海南医学,2006,17(12):140-142. 被引量:4
  • 2Dhooge C, De-Moerloose B. Clinical significance of P-glycoprotein (P- gp) expression in childhood acute lymphoblastic leukemia. Results of a 6-year prospective study[ J ]. Adv Exp Med Biol, 1999, 457 : 11 - 19.
  • 3Zhao L, Jin X, Xu Y, et al. Functional study of the novel multidrug resistance gene HA117 and its comparison to multidrag resistance gene l[J]. J Exp Clin Cancer Res, 2010, 29: 98.
  • 4Nooter K, Sonneveld P. Clinical relevance of P-glycoprotein expression in haematological malignancies[ J]. Leuk Res, 1994, 18 (4) : 233 - 243.
  • 5Zaman G J, Flens M J, van-Leusden M R, et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-elflux pump[J]. Proc Natl Acad Sci U S A, 1994, 91 (19) : 8822 -8826.
  • 6Abbaszadegan M R, Futscher B W, Klimecki W T, et al. Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic ceils[ J]. Cancer Res, 1994, 54 (17) : 4676 - 4679.
  • 7Manji G A, Wang L, Geddes B J, et al. PYPAF1, a PYRIN-containing Apafl-like protein that assembles with ASC and regulates activation of NF-kappa B [ J ]. J Biol Chem, 2002, 277 ( 13 ) : 11570 - 11575.
  • 8Wu G Q, Liao Y J, Qin Z Q, et al. PYRIN domain of NALP2 inhibits cell proliferation and tumor growth of human glioblastoma [ J ]. Plasmid, 2010, 64(1): 41 -50.
  • 9Huang ME,Ye YC,Chen SR.Use of all-trans retinoic acidin the treatment of acute promyelocytic leukemia [ J ] .Blood1988,72:567-572.
  • 10Sun R,Liu Y,Li SY,et al.Co-delivery of all-trans-retinoicacid and doxorubicin for cancer therapy with synergistic in-hibition of cancer stem cells [ J ]. Biomaterials, 2014,23,37C :405-414.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部